These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12870920)

  • 1. Development of a method for evaluating drug-likeness and ease of synthesis using a data set in which compounds are assigned scores based on chemists' intuition.
    Takaoka Y; Endo Y; Yamanobe S; Kakinuma H; Okubo T; Shimazaki Y; Ota T; Sumiya S; Yoshikawa K
    J Chem Inf Comput Sci; 2003; 43(4):1269-75. PubMed ID: 12870920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "In-house likeness": comparison of large compound collections using artificial neural networks.
    Muresan S; Sadowski J
    J Chem Inf Model; 2005; 45(4):888-93. PubMed ID: 16045282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic library design.
    Huwe CM
    Drug Discov Today; 2006 Aug; 11(15-16):763-7. PubMed ID: 16846805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection criteria for drug-like compounds.
    Muegge I
    Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A neural network based classification scheme for cytotoxicity predictions:Validation on 30,000 compounds.
    Molnár L; Keseru GM; Papp A; Lorincz Z; Ambrus G; Darvas F
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1037-9. PubMed ID: 16288868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico log P prediction for a large data set with support vector machines, radial basis neural networks and multiple linear regression.
    Chen HF
    Chem Biol Drug Des; 2009 Aug; 74(2):142-7. PubMed ID: 19549084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug discovery using support vector machines. The case studies of drug-likeness, agrochemical-likeness, and enzyme inhibition predictions.
    Zernov VV; Balakin KV; Ivaschenko AA; Savchuk NP; Pletnev IV
    J Chem Inf Comput Sci; 2003; 43(6):2048-56. PubMed ID: 14632457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of self-organizing neural networks in virtual screening and diversity selection.
    Selzer P; Ertl P
    J Chem Inf Model; 2006; 46(6):2319-23. PubMed ID: 17125175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANN-QSAR model of drug-binding to human serum albumin.
    Deeb O; Hemmateenejad B
    Chem Biol Drug Des; 2007 Jul; 70(1):19-29. PubMed ID: 17630991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'One bead two compound libraries' for detecting chemical and biochemical conversions.
    Meldal M
    Curr Opin Chem Biol; 2004 Jun; 8(3):238-44. PubMed ID: 15183321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated medicinal chemistry.
    Koppitz M; Eis K
    Drug Discov Today; 2006 Jun; 11(11-12):561-8. PubMed ID: 16713909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voyages to the (un)known: adaptive design of bioactive compounds.
    Schneider G; Hartenfeller M; Reutlinger M; Tanrikulu Y; Proschak E; Schneider P
    Trends Biotechnol; 2009 Jan; 27(1):18-26. PubMed ID: 19004513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CLEVER: pipeline for designing in silico chemical libraries.
    Song CM; Bernardo PH; Chai CL; Tong JC
    J Mol Graph Model; 2009 Jan; 27(5):578-83. PubMed ID: 18986817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pursuing the leadlikeness concept in pharmaceutical research.
    Hann MM; Oprea TI
    Curr Opin Chem Biol; 2004 Jun; 8(3):255-63. PubMed ID: 15183323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive activity profiling of drugs by topological-fragment-spectra-based support vector machines.
    Kawai K; Fujishima S; Takahashi Y
    J Chem Inf Model; 2008 Jun; 48(6):1152-60. PubMed ID: 18533712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular shape diversity of combinatorial libraries: a prerequisite for broad bioactivity.
    Sauer WH; Schwarz MK
    J Chem Inf Comput Sci; 2003; 43(3):987-1003. PubMed ID: 12767158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of topochemical models for the prediction of permeability through the blood-brain barrier.
    Dureja H; Madan AK
    Acta Pharm; 2007 Dec; 57(4):451-67. PubMed ID: 18165189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective optimization of side activities: another way for drug discovery.
    Wermuth CG
    J Med Chem; 2004 Mar; 47(6):1303-14. PubMed ID: 14998318
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of structural diversity in combinatorial synthesis.
    Fergus S; Bender A; Spring DR
    Curr Opin Chem Biol; 2005 Jun; 9(3):304-9. PubMed ID: 15939333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical library synthesis using convergent approaches.
    Beeler AB; Schaus SE; Porco JA
    Curr Opin Chem Biol; 2005 Jun; 9(3):277-84. PubMed ID: 15939329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.